Skip to main content
Rallis India Ltd logo

Rallis India Ltd — Investor Relations & Filings

Ticker · RALLIS ISIN · INE613A01020 LEI · 335800HI7I928BFJB442 BSE.NS Manufacturing
Open in API
Filings indexed 1,589 across all filing types
Latest filing 2023-03-08 Regulatory Filings
Country IN India
Listing BSE.NS RALLIS

About Rallis India Ltd

https://www.rallis.com/

Rallis India Ltd, a subsidiary of Tata Chemicals and a member of the Tata Group, specializes in providing comprehensive crop care solutions. The company's core business activities encompass the manufacturing and marketing of a diverse portfolio of agrochemicals, including insecticides, fungicides, and herbicides. Additionally, it maintains a significant presence in the seeds business, developing high-yielding hybrids for crops such as maize, paddy, and pearl millet. Rallis also offers plant growth nutrients and soil conditioners to enhance agricultural productivity. With a robust research and development framework and a vast distribution network, the company serves both domestic and international markets, exporting products to over 70 countries. Its operations are supported by integrated manufacturing facilities and a commitment to sustainable agricultural practices, positioning it as a key partner in the global agricultural value chain.

Recent filings

Filing Released Lang Actions
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of an analyst/institutional investor meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is about informing the exchanges and public about a scheduled investor meeting, explicitly stating that no unpublished price sensitive information will be shared. The document is short (1642 characters) and does not contain any financial data, report, or detailed presentation. It is an announcement of an event (investor meeting) rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-08 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of a scheduled meeting with an analyst/institutional investor. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which pertains to disclosure of material events. The content is about the schedule of an investor meeting and explicitly states no unpublished price sensitive information will be shared. The document length is short (1647 characters) and does not contain any financial data, report, or detailed presentation. It is an announcement of an event (investor meeting) rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of an analyst/institutional investor meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is about informing the exchanges and public about a scheduled investor meeting, with no financial data, report, or detailed presentation included. The document length is short (1647 characters), and it does not contain any financial statements or detailed analysis. It is an announcement of a meeting schedule rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of a scheduled meeting with an analyst/institutional investor. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is about the schedule of an investor meeting and explicitly states that no unpublished price sensitive information will be shared. The document is short (1659 characters) and does not contain any financial data, report, or results. It is an announcement of an event (investor meeting) rather than a financial report or detailed presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-03 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of an analyst/institutional investor meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is about informing the exchanges and public about the upcoming investor meeting date, venue, and type. There is no financial data, no report attached or published, no voting results, no management changes, no earnings or annual report content. The document is an announcement of a meeting schedule, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other specific categories.
2023-02-03 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings for February 2023. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is an announcement of upcoming investor meetings and explicitly states that no unpublished price sensitive information will be shared. The document is short (2239 characters) and does not contain any financial data, results, or detailed reports. It is an informational notice about scheduled meetings rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-01-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.